Clinical Trials in Maryland

Showing 7941-7960 of 17,687 trials

Cinrebafusp Alfa in Combination With Ramucirumab and Paclitaxel in HER2-High Gastric or GEJ Adenocarcinoma and in Combination With Tucatinib in HER2-Low Gastric or GEJ Andenocarinoma

NCT05190445

A Phase 2, multi-center, open-label study of cinrebafusp alfa (PRS-343) in combination with ramucirumab and paclitaxel in patients with HER2-high and in combination with tucatanib in patients with HER2-low gastric or gastroesophageal junction (GEJ) adenocarcinoma.

HER2-positive Gastric Cancer

Pieris Pharmaceuticals, Inc.80 participantsStarted Nov 2021

Santa Barbara, California, United States • Silver Spring, Maryland, United States • New York, New York, United States +2 more locations

COMPLETEDPhase 215 miles

A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis

NCT03486899

This is a study of experimental medication BMS-986036 given to adults with Nonalcoholic Steatohepatitis (NASH; the buildup of fat and inflammation in the liver that is not caused by alcohol) and stage 3 liver fibrosis (severe fibrosis).

Liver FibrosisNonalcoholic Fatty Liver Disease (NAFLD)Nonalcoholic Steatohepatitis

Bristol-Myers Squibb197 participantsStarted Jun 2018

Madison, Alabama, United States • Chandler, Arizona, United States • Phoenix, Arizona, United States +86 more locations

Cinrebafusp Alfa in Combination With Ramucirumab and Paclitaxel in HER2-High Gastric or GEJ Adenocarcinoma and in Combination With Tucatinib in HER2-Low Gastric or GEJ Andenocarinoma

A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis

Find Trials by Condition in Maryland

Ad/HER2/Neu Dendritic Cell Cancer Vaccine Testing

Preliminary Feasibility and Efficacy of Behavioral Intervention to Reduce Pain-Related Disability in Pediatric SCD

Healthy Behaviors Learning Task and Sleep

Biologic Mechanisms for Pain Variation After Physical Activity in Osteoarthritis

Safety, Tolerability, and Efficacy of AXA1125 in NASH With Fibrosis

A Study Of PF-05212384 In Combination With Other Anti-Tumor Agents and in Combination With Cisplatin in Patients With Triple Negative Breast Cancer in an Expansion Arm (TNBC)

Feasibility Study for GORE® TAG® Thoracic Branch Endoprosthesis to Treat Proximal Descending Thoracic Aortic Aneurysms

A Comparison Study of LY2140023 and Aripiprazole in Schizophrenia Patients

An Exploratory, Open-Label, Oligo-Center Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Intravenous DNV3837 in Subjects With Clostridium Difficile Infection

A Treatment Use Protocol for Subjects Continuing on From the Open-label Extension 0601

Lovastatin for the Treatment of Mildly Active Rheumatoid Arthritis

A Phase 2 Study Evaluating the Safety and Efficacy of Netarsudil Ophthalmic Solution in Patients With Corneal Edema Due to Fuchs Corneal Dystrophy

A Study of LY2140023 in Schizophrenia Patients With Prominent Negative Symptoms

Study to Assess if ABP798 is Safe & Effective in Treating Non Hodgkin Lymphoma Compared to Rituximab

Study to Evaluate the Safety and Efficacy of SDP-4 in Subjects With Dry Eye Disease (DED)

CR845-100303: Study to Assess the Potential of Physical Withdrawal From Intravenous CR845 (Difelikefalin) in Hemodialysis Patients

DELPHI in Subjects at Risk for Stroke and Dementia

Phase 1 Study to Assess the Safety, PK and PD of INBRX-101 in Adults With Alpha-1 Antitrypsin Deficiency